BioAgilytix doubled its customer base from 2013 to 2014 and already doubled again by August of this year. The company has 60 percent organic year-over-year growth and Datin expects to acquire a company in Europe by the end of the year. Last year, it worked with 12 of the 25 largest pharmaceutical and biotechnology companies, a figure that has increased to 19 this year.

[EPISODE 24] Dr. David Berkowitz Talks Enzymes, Radiation, And The Lincoln Marathon
On this episode of Molecular Moments, Chad Briscoe speaks with Dr. David Berkowitz, Director of the Division of Chemistry at